THE DIFFERENTIAL BEHAVIORAL-EFFECTS OF BENZAZEPINE D-1 DOPAMINE AGONISTS WITH VARYING EFFICACIES, CO-ADMINISTERED WITH QUINPIROLE IN PRIMATE AND RODENT MODELS OF PARKINSONS-DISEASE

被引:35
作者
GNANALINGHAM, KK
HUNTER, AJ
JENNER, P
MARSDEN, CD
机构
[1] UNIV LONDON KINGS COLL,DIV BIOMED SCI,PARKINSONS DIS SOC EXPTL RES LABS,LONDON WC2R 2LS,ENGLAND
[2] SMITHKLINE BEECHAM PHARMACEUT,HARLOW CM19 5AD,ESSEX,ENGLAND
[3] UNIV LONDON,NATL HOSP NEUROL,DEPT CLIN NEUROL,LONDON,ENGLAND
关键词
D-1 DOPAMINE AGONISTS; QUINPIROLE; MPTP; MARMOSET; RAT; 6-HYDROXYDOPAMINE; BEHAVIOR;
D O I
10.1007/BF02246103
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The effects of co-administration of quinpirole with benzazepine D-1 dopamine (DA) agonists possessing full/supramaximal (SKF 80723 and SKF 82958), partial (SKF 38393 and SKF 75670) and no efficacies (SKF 83959) in stimulating adenylate cyclase (AC) were investigated in rodent and primate models of Parkinson's disease (PD). In rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the medial forebrain bundle, co-administration of SKF 38393 (7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine), SKF 75670 (3-CH3 analogue), SKF 80723 (6-Br analogue), SKF 83959 (6-Cl, 3-CH3, 3'-CH3 analogue) and SKF 82958 (6-Cl, 3-C3H5 analogue) strongly potentiated the contralateral circling induced by quinpirole. In MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) treated common marmosets, administration of quinpirole alone increased locomotor activity and reversed motor deficits. Grooming and oral activity were unaltered. Go-administration of SKF 38393 and SKF 75670 inhibited the quinpirole-induced changes in locomotor activity and motor disability. The combined treatment of SKF 80723 or SKF 82958 with quinpirole had no overall effect on locomotor activity or motor disability. In contrast, SKF 83959 extended the duration of the quinpirole-induced increase in locomotor activity with corresponding decreases in motor disability. Go-administration of high doses of SKF 82958 and more especially SKF 83959 and SKF 80723, with quinpirole induced hyperexcitability and seizures. Oral activity and grooming were unaltered following the co-administration of benzazepine derivatives with quinpirole. The ability of some benzazepine D-1 DA agonists to prolong the antiparkinsonian effects of quinpirole in the MPTP-treated marmoset may indicate a role for certain D-1 DA agonists in the clinical treatment of PD. In general, the behavioural responses to the combined administration of benzazepines with quinpirole in the 6-OHDA lesioned rat and more especially the MPTP-treated marmoset failed to correlate with their ability to stimulate AC. These observations further implicate a behavioural role for D-1 DA receptors not linked to AC.
引用
收藏
页码:287 / 297
页数:11
相关论文
共 60 条
[1]   RELATIVE DOPAMINE D1 AND D2 RECEPTOR AFFINITY AND EFFICACY DETERMINE WHETHER DOPAMINE AGONISTS INDUCE HYPERACTIVITY OR ORAL STEREOTYPY IN RATS [J].
ARNT, J ;
BOGESO, KP ;
HYTTEL, J ;
MEIER, E .
PHARMACOLOGY & TOXICOLOGY, 1988, 62 (03) :121-130
[2]   PARTIAL AND FULL DOPAMINE D1-RECEPTOR AGONISTS IN MICE AND RATS - RELATION BETWEEN BEHAVIORAL-EFFECTS AND STIMULATION OF ADENYLATE-CYCLASE ACTIVITY INVITRO [J].
ARNT, J ;
HYTTEL, J ;
SANCHEZ, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 213 (02) :259-267
[6]   DOPAMINERGIC MECHANISMS AND MOTOR FUNCTION - CHARACTERIZATION OF D-1 AND D-2 DOPAMINE RECEPTOR INTERACTIONS [J].
BARONE, P ;
DAVIS, TA ;
BRAUN, AR ;
CHASE, TN .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 123 (01) :109-114
[7]   FUNCTIONAL RECOVERY OF D1 DOPAMINE RECEPTOR-MEDIATED STIMULATION OF RAT STRIATAL ADENYLATE-CYCLASE ACTIVITY FOLLOWING IRREVERSIBLE RECEPTOR MODIFICATION BY N-ETHOXYCARBONYL-2-ETHOXY-1,2-DIHYDROQUINOLINE (EEDQ) - EVIDENCE FOR SPARE RECEPTORS [J].
BATTAGLIA, G ;
NORMAN, AB ;
HESS, EJ ;
CREESE, I .
NEUROSCIENCE LETTERS, 1986, 69 (03) :290-295
[8]   EFFECT OF D1-RECEPTOR STIMULATION IN NORMAL AND MPTP MONKEYS [J].
BEDARD, PJ ;
BOUCHER, R .
NEUROSCIENCE LETTERS, 1989, 104 (1-2) :223-228
[9]   INHIBITION BY DOPAMINE OF (NA++K+)ATPASE ACTIVITY IN NEOSTRIATAL NEURONS THROUGH D1 AND D2 DOPAMINE RECEPTOR SYNERGISM [J].
BERTORELLO, AM ;
HOPFIELD, JF ;
APERIA, A ;
GREENGARD, P .
NATURE, 1990, 347 (6291) :386-388
[10]   DIFFERENTIAL-EFFECTS OF D1 AND D2 AGONISTS IN MPTP-TREATED PRIMATES - FUNCTIONAL IMPLICATIONS FOR PARKINSONS-DISEASE [J].
BOYCE, S ;
RUPNIAK, NMJ ;
STEVENTON, MJ ;
IVERSEN, SD .
NEUROLOGY, 1990, 40 (06) :927-933